Skip to main content
. 2021 Jun 9;12(7):1947–1963. doi: 10.1007/s13300-021-01088-w

Table 2.

Cost and utility inputs

Item Value Range References
Costs
 Heart failure (per event)
  Heart failure hospitalization 88,313 70,650–105,976 Deerochanawong [20]
 Diabetes (per year)
  Diabetes treatment 21,240 16,992–25,488 Riewpaiboon [21]
 Chronic kidney disease (per year)
  Predialysis 85,478 68,382–102,573 Deerochanawong [20]
  Dialysis set up 32,681a 26,145–39,217 Teerawattananon [22]
  Dialysis 557,623 446,098–669,147
  Transplantation 379,021 303,217–454,826 NHSO [23]
  Follow-up after transplantation (first 2 years) 47,500 38,000–57,000
  Follow-up after transplantation (third year and onward) 15,000 12,000–18,000
 Drug (per year)
  Dapagliflozin 14,638 11,710–17,565 DMSIC [24]
 Adverse eventsb (per event)
  Major hypoglycemic event 51,607 2346–100,867 Siriraj hospital database [25]
  Diabetic ketoacidosis 64,763 14,388–115,138
  Acute kidney injury 110,906 95,051–316,864
  Genital infection 11 DMSIC [24]
Direct non-medical cost
 Heart failure and diabetesc (per event)
  Transportation 155 143–168 Standard cost list [26]
  Food 57 51–63
 Chronic kidney disease (per year)
  Normoalbuminuria 1045 836–1254 Srisubat [17]
  Microalbuminuria 1400 1120–1680
  Macroalbuminuria 2116 1693–2540
  Dialysis 8170 6536–9804
Utilities
 Heart failure
  Hospitalization 0.65 0.55–0.75 Adena [37]
  Stable 0.75 0.65–0.85
 Diabetes
  Diabetes 0.814 0.733–0.895 Clarke [38]
 Chronic kidney disease
  Normoalbuminuria 0.72 0.696–0.744 Srisubat [17]
  Microalbuminuria 0.72 0.696–0.744
  Macroalbuminuria 0.59 0.549–0.631
  Dialysis 0.55 0.499–0.601
  Transplantation 0.83 0.747–0.913 Li [39]

DMSIC Drug and Medical Supply Information Center, NHSO the National Health Security Office

aAverage on the proportion of peritoneal dialysis (30%) and hemodialysis (70%)

bCost of adverse event treatment = cost per event × prevalence of such adverse event

cPatients visit a hospital 4 times per year. Direct non-medical cost per year = cost per event × 4